PCSK9 causes inflammation and cGAS / STING pathway activation in diabetic nephropathy
The FASEB Journal · 2023-09 · 37 (9)
DOI: 10.1096/fj.202300342rrr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 10.08.2023. Verfasst von Zhicai Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Nephropathies, Proprotein Convertase 9. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Our previous research revealed that an increase in PCSK9 is linked to aggravated inflammation in the kidneys of mice affected by a high‐fat diet and streptozotocin (HFD/STZ) or in HGPA‐induced HK‐2 cells. Furthermore, the cGAS/STING pathway has been reported to be involved in diabetic nephropathy (DN). Therefore, in this study, we aimed to examine the correlation between the proinflammatory effect of PCSK9 and the cGAS/STING pathway in DN. We used PCSK9 mAbs to inhibit PCSK9 in vivo and PCSK9 siRNA in vitro and measured the inflammatory phenotype in HFD/STZ‐treated mice or HGPA‐induced HK‐2 cells, and observed decreased blood urea nitrogen, creatinine, UACR, and kidney injury in response to the PCSK9 mAb in HFD/STZ‐treated mice. Moreover, IL‐1 β, MCP‐1, and TNF‐α levels were reduced by the PCSK9 mAb in vivo and PCSK9 siRNA in vitro. We observed increased mtDNA damage and activation of the cGAS‐STING signaling pathway during DN, as well as the downstream targets p‐TBK1, p‐NF‐κB p65, and IL‐1β. In a further experiment with an HGPA‐induced DN model in HK‐2 cells, we revealed that mtDNA damage was increased, which led to the activation of the cGAS/STING system and its downstream targets. Notably, the cGAS‐STING signaling pathway was inhibited by the PCSK9 mAb in vivo and PCSK9 siRNA in vitro. In addition, inhibition of STING with C‐176 in HGPA‐induced HK‐2 cells markedly blocked inflammation. In conclusion, we report for the first time that PCSK9 triggers mitochondrial DNA damage and activates the cGAS‐STING pathway in DN, which leads to a series of inflammation cascades. PCSK9‐targeted intervention can effectively reduce DN inflammation and delay its progression. Moreover, the inhibition of STING significantly abrogated the inflammation triggered by HGPA in HK‐2 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, the Third Xiangya Hospital, Central South University, Changsha, China.
- The Critical Kidney Disease Research Center of Central South University, Changsha, China.
- Furong Laboratory, Changsha, China.
- Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Feng, Z., Liao, X., Peng, J., Quan, J., Zhang, H., Huang, Z., & Yi, B. (2023). PCSK9 causes inflammation and cGAS / STING pathway activation in diabetic nephropathy. The FASEB Journal, 37(9). https://doi.org/10.1096/fj.202300342rrr
Vancouver
Feng Z, Liao X, Peng J, Quan J, Zhang H, Huang Z, et al. PCSK9 causes inflammation and cGAS / STING pathway activation in diabetic nephropathy. The FASEB Journal. 2023;37(9). doi:10.1096/fj.202300342rrr
BibTeX
@article{Feng2023,
author = {Feng, Zhicai and Liao, Xiangyu and Peng, Juan and Quan, Jingjing and Zhang, Hao and Huang, Zhijun and Yi, Bin},
title = {PCSK9 causes inflammation and cGAS / STING pathway activation in diabetic nephropathy},
journal = {The FASEB Journal},
year = {2023},
volume = {37},
number = {9},
doi = {10.1096/fj.202300342rrr}
}
EUVIMED